TENAX THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tenax Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Tenax Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 3.41M shares, a 85.7% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 3.41M -20.5M -85.7% Oct 31, 2024 10-Q 2024-11-13
Q2 2024 3.41M -20.5M -85.7% Aug 10, 2024 10-Q 2024-08-13
Q1 2024 1.96M -20.4M -91.3% Mar 20, 2024 10-K 2024-03-28
Q3 2023 23.9M -20.8M -46.6% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 23.9M -1.34M -5.33% Aug 7, 2023 10-Q 2023-08-14
Q1 2023 22.4M -2.81M -11.1% Mar 28, 2023 10-K 2023-03-31
Q3 2022 44.7M +19.5M +77.3% Nov 7, 2022 10-Q 2022-11-10
Q2 2022 25.2M +5.6K +0.02% Aug 8, 2022 10-Q 2022-08-11
Q1 2022 25.2M +10.2M +68.4% Mar 28, 2022 10-K 2022-03-29
Q3 2021 25.2M +12.6M +99.7% Nov 12, 2021 10-Q 2021-11-15
Q2 2021 25.2M +12.6M +99.7% Aug 12, 2021 10-Q 2021-08-16
Q1 2021 15M +7.36M +96.8% Mar 25, 2021 10-K/A 2021-04-16
Q3 2020 12.6M +5.88M +87.2% Nov 12, 2020 10-Q 2020-11-16
Q2 2020 12.6M +5.88M +87.2% Aug 11, 2020 10-Q 2020-08-14
Q1 2020 7.61M +1.45M +23.6% Mar 27, 2020 10-K 2020-03-30
Q3 2019 6.74M +5.28M +360% Nov 11, 2019 10-Q 2019-11-14
Q2 2019 6.74M +5.28M +360% Aug 9, 2019 10-Q 2019-08-14
Q1 2019 6.15M +4.73M +331% Mar 27, 2019 10-K 2019-04-01
Q3 2018 1.47M -26.8M -94.8% Nov 12, 2018 10-Q 2018-11-14
Q2 2018 1.47M -26.8M -94.8% Aug 10, 2018 10-Q 2018-08-14
Q1 2018 1.43M -26.7M -94.9% Mar 28, 2018 10-K 2018-04-02
Q3 2017 28.2M +117K +0.42% Nov 4, 2017 10-Q 2017-11-09
Q2 2017 28.2M +117K +0.42% Aug 4, 2017 10-Q 2017-08-09
Q1 2017 28.1M +250 +0% Mar 9, 2017 10-K 2017-03-16
Q3 2016 28.1M +327 +0% Nov 7, 2016 10-Q 2016-11-09
Q2 2016 28.1M +327 +0% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 28.1M +335 +0% Mar 9, 2016 10-KT 2016-03-14
Q4 2015 28.1M +335 +0% Dec 8, 2015 10-Q 2015-12-10
Q3 2015 28.1M +20M +247% Sep 8, 2015 10-Q 2015-09-09
Q2 2015 28.1M +12.3K +0.04% Jul 10, 2015 10-K 2015-07-14
Q1 2015 28.1M +11M +63.9% Mar 13, 2015 10-Q 2015-03-17
Q4 2014 28.1M +17.5M +165% Dec 12, 2014 10-Q 2014-12-15
Q3 2014 8.11M +3.06M +60.5% Sep 12, 2014 10-Q 2014-09-15
Q2 2014 28.1M +26M +1240% Jul 24, 2014 10-K 2014-07-29
Q1 2014 17.2M -21.2M -55.2% Mar 14, 2014 10-Q 2014-03-17
Q4 2013 10.6M -22.5M -67.9% Dec 16, 2013 10-Q 2013-12-17
Q3 2013 5.05M -27.3M -84.4% Sep 12, 2013 10-Q 2013-09-17
Q2 2013 2.1M -29M -93.3% Jun 20, 2013 10-K 2013-06-26
Q1 2013 38.3M +9.29M +32% Mar 15, 2013 10-Q 2013-03-18
Q4 2012 33.1M +9.28M +38.9% Dec 12, 2012 10-Q 2012-12-14
Q3 2012 32.3M +8.56M +36% Sep 18, 2012 10-Q 2012-09-19
Q2 2012 31.1M Jul 20, 2012 10-K 2012-07-25
Q1 2012 29M Mar 13, 2012 10-Q 2012-03-15
Q4 2011 23.9M Dec 12, 2011 10-Q 2011-12-15
Q3 2011 23.8M Sep 19, 2011 10-Q 2011-09-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.